Cure My Disease

Don't miss your cure!

 Log in / Sign up

Step-by-Step strategy aims to boost use of opioid addiction medications in clinics

NCT ID NCT05343793

Disease control Sponsor: Stanford University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 06, 2026 · Last updated Jul 29, 2026 · Updated 5 times

Summary

This study tests a staged approach to help addiction treatment programs in Washington State increase their use of medications for opioid use disorder (MOUD). Clinics start with simple feedback reports and, if needed, move to more intensive support like workshops and coaching. The goal is to see which combination of strategies works best to get more patients started on and staying with medications like buprenorphine or naltrexone.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Enhanced Monitoring and Feedback, NIATx/MAT Academy, Internal and External Facilitation
What this could lead to
If successful, this approach could help more addiction clinics nationwide adopt medications for opioid use disorder, improving treatment access and patient outcomes.
What could go wrong
This is an implementation study, not a drug trial. It tests how to change clinic behavior, not a new treatment. Results may vary across clinics and may not apply outside Washington State.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

70 people

The number who actually took part.

Started

Mar 2022

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Addiction treatment programs in Washington State * Residential (detoxification or rehabilitation) or outpatient (intensive outpatient or outpatient) levels of care * Primary care clinics, including Federally Qualified Health Centers (FQHCs) and Community Health Centers (CHCs) Exclusion Criteria: * Opioid treatment programs

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Addiction, opioid are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Addiction, opioid

Contacts and locations

Locations

  • Washington State Healthcare Authority

    Olympia, Washington, 98501, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.